The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Bhupendra Vithaldas Gandhi
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Bhupendra Vithaldas Gandhi, part of the promoter group of Hester Biosciences, has sold 1,111 equity shares (about 0.01% of the company's equity capital) to fellow promoter Mr. Rajiv Dinesh Gandhi on 4 September 2025. The transaction was carried out off-market as an inter-se transfer within the promoter family/promoter group entities. Post-transaction, the aggregate promoter and promoter group shareholding remains unchanged at 53.73% (45,70,944 shares). All other promoter group members' holdings remain identical to pre-transaction levels.
This is a routine internal reshuffling between promoter family members with no change in total promoter ownership, so it is effectively neutral for shareholders and the stock price. No signals of any meaningful stake change, pledge activity, or creeping acquisition are present.